atomoxetine
UkraineDrugs containing this active substance
-
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults.
Form: capsules, hard
Active substance Dosage atomoxetine 10 mg ATC: N06BA09
Manufacturer: Farmaten International S.A. (manufacturing, packaging, quality control and batch release of medicinal product)
-
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults as part of a comprehensive treatment program.
Form: capsules, hard
Active substance Dosage atomoxetine 40 mg ATC: N06BA09
Manufacturer: Farmaten International S.A. (manufacturing, packaging, quality control and batch release of medicinal product)
-
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults.
Form: capsules, hard
Active substance Dosage atomoxetine 18 mg ATC: N06BA09
Manufacturer: Farmaten International S.A. (manufacturing, packaging, quality control and batch release of medicinal product)
-
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults.
Form: capsules, hard
Active substance Dosage atomoxetine 25 mg ATC: N06BA09
Manufacturer: Farmaten International S.A. (manufacturing, packaging, quality control and batch release of medicinal product)
-
The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older and in adults as part of a comprehensive treatment program.
Form: capsules
Active substance Dosage atomoxetine 10 mg ATC: N06BA09
Manufacturer: Pharmascience Inc. (manufacturing of unpackaged product, primary and secondary packaging, quality control, batch release)
-
The drug is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older and adults as part of a comprehensive treatment program.
Form: capsules
Active substance Dosage atomoxetine 18 mg ATC: N06BA09
Manufacturer: Pharmascience Inc. (manufacturing of unpackaged product, primary and secondary packaging, quality control, batch release)
-
The drug is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older and in adults as part of a comprehensive treatment program.
Form: capsules
Active substance Dosage atomoxetine 25 mg ATC: N06BA09
Manufacturer: Pharmascience Inc. (manufacturing of unpackaged product, primary and secondary packaging, quality control, batch release)
-
The drug is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older and in adults as part of a comprehensive treatment program.
Form: capsules
Active substance Dosage atomoxetine 40 mg ATC: N06BA09
Manufacturer: Pharmascience Inc. (manufacturing of unpackaged product, primary and secondary packaging, quality control, batch release)
-
The drug is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older and adults as part of a comprehensive treatment program.
Form: capsules
Active substance Dosage atomoxetine 60 mg ATC: N06BA09
Manufacturer: Pharmascience Inc. (manufacturing of unpackaged product, primary and secondary packaging, quality control, batch release)